Go Pro
→ It’s not about Greenland (From Porter & Company) (Ad)tc pixel
LON:DXRX

Diaceutics Final Earnings Report

Diaceutics logo
GBX 145 +1.50 (+1.05%)
As of 11:50 AM Eastern
ProfileEarnings HistoryForecast

Diaceutics EPS Results

Actual EPS
GBX 11
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
$38.44 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Diaceutics Announcement Details

Quarter
Final
Date
5/26/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Diaceutics Earnings Headlines

Diaceutics and PCC Launch NGS Study to Boost Confidence in Cancer Diagnostics
August 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-and-pcc-launch-ngs-study-to-boost-confidence-in-cancer-diagnostics?utm_source=marketbeat.com&utm_medium=referral
Diaceutics boosts employee share incentives and updates total voting rights
August 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-boosts-employee-share-incentives-and-updates-total-voting-rights?utm_source=marketbeat.com&utm_medium=referral
The New Kings of Cantillon
In 1720, Richard Cantillon discovered that new money never spreads evenly through an economy. It reaches certain hands first and everyone else pays for it later. Fifty years after the petrodollar reshaped global wealth, a new monetary reset may be underway, this time tied to critical minerals, energy, and AI infrastructure. Stocks like Vertiv, GE Vernova, Arista Networks, and Taseko Mines have already posted major gains since the shift began. Porter Stansberry breaks down the full story, including which companies sit closest to the new money flow.tc pixel
August 26 at 1:00 AM  |  Porter & Company (Ad)
Diaceutics Issues Shares Under Employee Incentive Schemes in Latest Block Listing Update
April 7, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-shares-under-employee-incentive-schemes-in-latest-block-listing-update?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Executes Routine Management Share Purchases Under Incentive Plan With No Change to Share Capital
April 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-executes-routine-management-share-purchases-under-incentive-plan-with-no-change-to-share-capital?utm_source=marketbeat.com&utm_medium=referral
Diaceutics Issues New Shares to Trust as PDMRs Participate in Incentive Plan
February 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/diaceutics-issues-new-shares-to-trust-as-pdmrs-participate-in-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile
Earnings Tools